In terms of DSS, higher DBF4B expression was associated with worse prognosis in subgroups such as Age > 60, BMI ≤ 25, Race: Asian, Gender: male, Residual tumor: R0, Histological type: Hepatocellular carcinoma, Pathological stage: Stage III, Tumor state: With tumor, Pathological T stage: T3 (Figure S19). This evidence concerns the gene DBF4B and hepatocellular carcinoma.